*To the Editor*:

I read with interest the study by Roca and coworkers ([@bib1]) on the ROX index, which combines the oxygen saturation as measured by pulse oximetry (Sp~O~2~~)/F[i]{.smallcaps}~O~2~~ ratio and the respiratory rate, and predicts the outcome of nasal high-flow (NHF) therapy in patients with acute respiratory failure caused by pneumonia. The index is based on two well-known facts: sicker patients require more oxygen and have higher respiratory rates. The study demonstrated that a ROX index of ≥4.88 at 2, 6, or 12 hours determines the success of the therapy. The authors noted that "among components of the index, Sp~O~2~~/F[i]{.smallcaps}~O~2~~ had a greater weight than respiratory rate." This highlights the role of F[i]{.smallcaps}~O~2~~ requirements in the success of NHF therapy for unstable patients with respiratory failure.

The figure of the calculated ROX index presented here may be complementary to the study ([Figure 1](#fig1){ref-type="fig"}) and may help to elucidate the index's value and the relationship between F[i]{.smallcaps}~O~2~~ and respiratory rates.

![Relationship between F[i]{.smallcaps}~O~2~~ and the ROX index at Sp~O~2~~ 95% for a range of respiratory rates between 20 and 40 breaths/min. Respiratory rates are shown in the same order as in the key. The gray area indicates ROX \< 4.88. F[i]{.smallcaps}~O~2~~ values of 0.5 and 0.8 are marked with dashed vertical lines. Sp~O~2~~ = oxygen saturation as measured by pulse oximetry.](rccm.201902-0376LE_f1){#fig1}

The ROX index was calculated for Sp~O~2~~ of 95% and respiratory rates of 20--40 breaths/min using a range of F[i]{.smallcaps}~O~2~~ values from 0.4 to 1.0. The gray area indicates ROX values below a cutoff point of 4.88 ([@bib1]).

Respiratory rates in oxygen-dependent patients are expected to be increased. The figure reveals that the ROX index is unlikely to drop below 4.88 with F[i]{.smallcaps}~O~2~~ values of up to 0.5, and it would be under the cutoff point with F[i]{.smallcaps}~O~2~~ values of 0.8 or higher for the anticipated range of respiratory rates. F[i]{.smallcaps}~O~2~~ values of 0.5 and 0.8 are marked with interrupted vertical lines. If Sp~O~2~~ is under or above 95%, all of the presented curves of the calculated ROX will shift slightly downward or upward, respectively.

The index is very simple and has the potential to become a routine parameter in clinical practice when supplemental oxygen is used with NHF therapy. The presented figure may help to predict when a patient is expected to fail and could be considered for escalation of care.
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